The estimated Net Worth of Enterprise Associates 9 L P... is at least $3.53 million dollars as of 23 March 2016. Enterprise P owns over 1,052,631 units of Senseonics Inc stock worth over $3,525,126 and over the last 9 years Enterprise sold SENS stock worth over $0.
Enterprise has made over 1 trades of the Senseonics Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently Enterprise bought 1,052,631 units of SENS stock worth $2,999,998 on 23 March 2016.
The largest trade Enterprise's ever made was buying 1,052,631 units of Senseonics Inc stock on 23 March 2016 worth over $2,999,998. On average, Enterprise trades about 1,052,631 units every 0 days since 2016. As of 23 March 2016 Enterprise still owns at least 8,949,292 units of Senseonics Inc stock.
You can see the complete history of Enterprise P stock trades at the bottom of the page.
Enterprise's mailing address filed with the SEC is 1954 GREENSPRING DRIVE1954 GREENSPRING DRIVE, SUITE 600SUITE 600, TIMONIUMTIMONIUM, MDMD, 2109321093.
Over the last 9 years, insiders at Senseonics Inc have traded over $36,720,504 worth of Senseonics Inc stock and bought 30,963,337 units worth $56,759,340 . The most active insiders traders include Peter J Barris, M James Barrett et Douglas A Roeder. On average, Senseonics Inc executives and independent directors trade stock every 45 days with the average trade being worth of $313,683. The most recent stock trade was executed by Sharon Larkin on 7 September 2023, trading 30,889 units of SENS stock currently worth $18,842.
senseonics, inc. is a medical device startup company in germantown, maryland, usa (near washington, dc) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. utilizing breakthrough fluorescence sensing technology, the senseonics continuous glucose monitoring ("cgm") system is being designed to be the first fully implantable cgm that is highly accurate and stable throughout its long sensor life. the system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.
Senseonics Inc executives and other stock owners filed with the SEC include: